Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.
Also called NCT01559298
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 178 participants
- Sponsor
- Registry
-
NCT01559298
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Canada
- Registry status
- Completed
Technical summary
Registry record NCT01559298. Randomized; no masking; primary purpose prevention. Start 2012-03 (actual); primary completion 2015-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Aspirin Versus Aspirin + ClopidogRel Following Transcatheter Aortic Valve Implantation: the ARTE Trial
- Acronym
- ARTE
- Condition
- Aortic Valve Disease
- Condition
- Myocardial Infarction
- Condition
- Stroke
- Intervention (Drug)
- Aspirin (80 mg/d) + clopidogrel (75 mg/d)
- Intervention (Drug)
- Aspirin
- Lead sponsor
- Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
- Collaborator
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct01559298- Content hash
f8e0a433c5fb1b21c233712c0a81ae7668d6207aff1f26d721c1f64336450805